Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.0050 CAD
Change Today 0.00 / 0.00%
Volume 0.0
GES On Other Exchanges
As of 11:25 AM 08/24/15 All times are local (Market data is delayed by at least 15 minutes).

gemoscan canada inc (GES) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/19/14 - C$0.04
52 Week Low
01/15/15 - C$0.0050
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GEMOSCAN CANADA INC (GES)

Related News

No related news articles were found.

gemoscan canada inc (GES) Related Businessweek News

No Related Businessweek News Found

gemoscan canada inc (GES) Details

Gemoscan Canada, Inc. develops, owns, and markets food sensitivity and dietary management solutions for consumers in Canada. Its solutions include HEMOCODE food intolerance system, a personalized naturopathic nutritional program that promotes well-being. This system also provides personalized dietary guidelines and replacement food suggestions. The company commercializes its food intolerance management solution directly to consumers in partnership with retailers. It has strategic alliance with A.C. Simmonds and Sons. Gemoscan Canada, Inc. was founded in 2003 and is headquartered in Toronto, Canada.

Founded in 2003

gemoscan canada inc (GES) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: C$211.3K
Chief Financial Officer and Secretary
Total Annual Compensation: C$56.0K
Compensation as of Fiscal Year 2014.

gemoscan canada inc (GES) Key Developments

Gemoscan Canada, Inc. Auditor Raises 'Going Concern' Doubt

Gemoscan Canada, Inc. filed its Annual on Jul 30, 2015 for the period ending Mar 31, 2015. In this report its auditor, Zeifman & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Gemoscan Canada, Inc. Announces Resignation of Elisa Swern as Director

Gemoscan Canada, Inc. announced the resignation of Elisa Swern as a director of Gemoscan. Ms. Swern tendered her resignation effective February 28, 2015. The Board of Directors wish Ms. Swern all the best in her future endeavors.

Gemoscan Canada, Inc. Forms Strategic Alliance with A.C. Simmonds and Sons

Gemoscan Canada, Inc. announced that it has formed a strategic alliance with A.C. Simmonds and Sons. The Alliance will focus on corporate and business development initiatives focused around Gemoscan's previously stated goals of leveraging its patented intellectual property and proprietary processes to become one of the integrated platforms in the rapidly growing multi-billion dollar North American consumer based healthcare market. The Alliance will help the Company to further expand its position in the health and wellness industry, with a particular focus on natural remedies and treatments.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GES:CN C$0.01 CAD 0.00

GES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GES.
View Industry Companies

Industry Analysis


Industry Average

Valuation GES Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GEMOSCAN CANADA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at